Summary:
Adhesion study to compare a test fentanyl transdermal patch to a reference fentanyl patch.
Qualified Participants Must:
Healthy males and females according to the assessment of the investigator, based on a complete medical history and physical exam.
Between the ages of 18-55
BMI of 18-32
Minimum weight of 120
Male subjects must use with their partner an approved method of highly effective contraception from time of informed consent through at least 30 days after completion of study
Female subjects must meet at least one of the following requirements:
- Have used and agree to continue to use a reliable method of contraception (e.g., condom with diaphragm or cap, IUD, hormonal contraceptives) for at least 30 days before initial dosing and for at least 30 days following completion of the study
- Surgically sterile (bilateral oophorectomy or hysterectomy, lateral tubal ligation at least 3 months before initial dosing or Assure device placement before the year 2018).
- At least 1 year postmenopausal and have a documented FSH level > 40 at screening.
Qualified Participants May Receive:
Compensation for participating up to $1,600 over the study length. 5days / 5 nights